Dr. John Maris receives William Osler Patient Oriented Research Award

December 14, 2010

The Penn Almanac

Dr. John M. Marisis the winner of the William Osler Patient Oriented Research Award. He has made seminal contributions to the field of pediatric cancer. His research focuses on understanding the molecular pathogenesis of neuroblastoma as well as developing innovative clinical approaches to treatment of this disease through the national oncology groups where he holds administrative appointments, including chair of the Children’s Oncology Group Neuroblastoma Disease Committee and chair of the New Approaches to Neuroblastoma Therapy Study Committee. His work led to the first clinical trial of a molecularly targeted therapy for neuroblastoma. His research has been continuously supported by external funding. He has contributed substantially to the scholarship in his field. He is on the editorial boards of Pediatric Blood and Cancer and the Journal of Clinical Investigation. He is a grant reviewer for many national and international organizations and, in 2008, was appointed as a charter member of the NIH/NCI Cancer Genetics Study Section. In 2007, he was elected to the American Society of Clinical Investigation and he received the Oski Award from the American Society of Pediatric Hematology/Oncology. Dr. Maris’ contributions to teaching in the research and clinical settings have been equally impressive. He was Program Director of the CHOP Hematology/Oncology Fellowship from 2001 through 2008. He received the 2009 Leonard Berwick Memorial Teaching Award, a Penn Medicine Award of Excellence. He frequently lectures nationally and internationally and has held organizing roles in a number of scientific meetings.

View Original Article